Keywords: fda, delays, protherics, voraxaze, til, uk, drugmaker
FDA delays Protherics' Voraxaze til 2008
Article | 13 November 2006
UK drugmaker Protherics says that the US Food and Drug Administration has requested additional manufacturing data following its Biologicals License ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
